World’s No. 1 memory chipmaker seemingly takes cautious approach to reduce impact on market sentiment, keeps strategies under wraps

Less than a 5-minute walk away from Apple Store, Samsung venue attracts visitors with eye-catching products, immersive experience

Korean pharmaceutical firm Chong Kun Dang said Monday that it signed a licensing deal with Dutch company Synaffix to gain access to the latter's technologies needed to develop new antibody drug conjugates. The size of the deal, which was inked Friday, is estimated at around $132 million, plus tiered royalties on commercial sales in the future. “The company will speed up development of next-generation anti-cancer treatment through the latest deal with Synaffix,” said Chong Kun Da

SAN FRANCISCO -- Samsung Electronics is hoping to expand its presence in the global laptop market where it remains a tiny player, as people are replacing their laptops more frequently after pandemic disruptions. “The replacement cycle of laptops is getting shorter from the previous life span of five years on average since the electric devices are turning into true ‘personal computers’ during the pandemic years,” said Lee Min-cheol, corporate vice president of Samsung&rsqu

LG Group said Monday it has kicked off the construction to renovate the lower floors of its symbolic LG Twin Towers, a landmark in Yeouido, western Seoul, where its major affiliates including LG Electronics are headquartered. Since the buildings were established in 1987, it is the second time the nation's fourth-largest conglomerate carries out a renovation of the two skyscrapers. It renovated the working spaces in the upper level floors in 2009, and it is the it is the first time the group

Non-fungible artworks by renowned artist Barry X Ball are showcased on LG Electronics’ digital billboard in iconic Times Square in New York City on Sunday. The attached QR code allows visitors to experience the tech giant’s NFT art trade platform LG Art Lab.

SAN FRANCISCO -- Samsung Electronics unveiled the new Galaxy S23 smartphones, the latest lineup of its flagship S series, on Wednesday, putting much emphasis on enhanced camera functions -- a secret weapon to fight against its archrival, Apple. “We’ve enhanced our camera system that allows users to take the best photos and videos in any environment. … The Galaxy S23 series not only comes with a 200-megapixel sensor but also provides a satisfactory camera experience with more

Race to advance AI-powered search engines heats up as Microsoft bets big on ChatGPT to upgrade Bing

South Korean internet giant Naver said Friday it will launch its own generative pretrained transformer, or GPT, for search functions by the end of June, as OpenAI's artificial intelligence chatbot ChatGPT has been taking the tech world by storm. “We are gearing up to handle new search trends, such as the generative AI that is gaining a lot of attention now. And we plan to introduce our own upgraded version of SearchGPT in the first half of this year,” Chief Executive Officer Cho

Korean biopharmaceutical firm SK Bioscience is expected to log a sharp decline in its sales and operating profit for 2022, as demand wanes for COVID-19 vaccines, its key source of revenue, according to a report from a local securities firm on Friday. The company’s annual sales for last year are expected to drop 49 percent on-year to 474.2 billion won ($385.7 million), while its operating profit is also expected to plunge 70.3 percent to 141 billion won, the report released by Meritz Securi

Mobile chief confident in tackling mobile slump with S23 series without drastic price hikes

Tech giants join forces to create renewed alliance on XR technology

Tech giant holds first in-person unveiling event for flagship phones after 3 years of pandemic disruptions

The combination use of Jiangsu Hengrui Medicine’s camrelizumab and HLB Bio’s rivoceranib has received a novel drug approval from the National Medical Products Administration of China, HLB Bio announced Wednesday. With the approval, the camrelizumab-rivoceranib combination can be used as the first-line treatment for patients with unresectable hepatocellular carcinoma in China. The approval was given three years and nine months after the company started its phase 3 clinical trial April

Amid severe downturn in global chip market, firm reports first quarterly operating loss in decade